Govt Job: For M.Pharm in Research at Institute of Chemical Technology

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists.

The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs.

The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002.

Post : Project Fellow

Project Title :Development of exotic spice blends and related food products

Sponsor : M/s. Duval Enterprises Pvt Ltd

Project Investigator :Prof.K.S.Laddha

No. of Posts : One (01)

Project duration : 2 years

Eligibility : Master of Pharmacy

Fellowship : Rs.20,000/-p.m consolidated

The project fellow will be appointed initially for 6 months/one year and the tenure may be extended based on performance for the subsequent period. All appointments are terminated with end of the project.

Interested candidates should send their applications including cover letter, Curriculum vitae by email (research.assistant@staff.ictmumbai.edu.in)

The copy should also be forwarded to ks.laddha@ictmumbai.edu.in Please mention in the subject of email “Application for the post of Project Fellow Project Name Development of exotic spice blends and related food products”.

The applications should reach before 15 days from the advertisement date, along with cover letter, Curriculum vitae.

The interview will be held online after receiving and short listing of candidates. Selection will be based on an interview conducted by a committee.

The recommendation of the committee will be final. No TA/DA will be provided to appear for this interview.

Last Date : 4th February, 2022

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework